Medical supplies contracts in Germany

1,508 open tenders

CountryTenderValueClosesDays left

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Calcipotriol + Betamethasone (excluding Dafo. CRE), for the period 01.07.26 – 30.06.28 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 333193-2026

€11 lot, 2 years

Sat 5 May12:00 in Berlin

919days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Betamethasone and Salicylic Acid (excluding Dafo. LOE), for the period 01.07.26 – 30.06.28 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 334368-2026

€11 lot, 2 years

Sat 5 May12:00 in Berlin

919days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Risperidone (excluding Dafo. PLD), ATC N05AX08 for the period 01.07.26 - 30.06.28 (including V.-option 1x12 months)

DAK-Gesundheit, HamburgTED 332185-2026

€11 lot, 2 years

Sat 5 May12:00 in Berlin

919days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Promethazine (excluding Dafo. TEI), ATC N05CM22 for the period 01.07.26 - 30.06.28 (including V.-option 1x12 months)

DAK-Gesundheit, HamburgTED 331735-2026

€11 lot, 2 years

Sat 5 May12:00 in Berlin

919days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Testosterone (excluding Testosterone Enanthate), for the period 01.07.26 – 30.06.28 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 343017-2026

€11 lot, 2 years

Sat 5 May12:00 in Berlin

919days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Vigabatrin (excluding Dafo. FTA), ATC N03AG04 for the period 01.07.26 - 30.06.28 (including V.-option 1x12 months)

DAK-Gesundheit, HamburgTED 331975-2026

€11 lot, 2 years

Sat 5 May12:00 in Berlin

919days

Conclusion of a non-exclusive discount agreement under § 130a, paragraph 8 of the German Social Security Code (SGB V) for the active substance Dabigatran (excluding standard size N3), ATC code B01AE07 as of 01.7.26 - 30.6.28 (including V.-option 1x12 Mon)

DAK-Gesundheit, HamburgTED 332830-2026

€11 lot, 2 years

Sat 5 May12:00 in Berlin

919days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Spironolactone (excluding strength 25 mg), ATC C03DA01, for the period 01.07.26 – 30.06.28 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 331200-2026

€11 lot, 2 years

Sat 5 May12:00 in Berlin

919days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Ofloxacin (excl. Dafo. KPG), ATC S01AE01, for the period 01.08.2026 – 31.07.2028 (plus extension option 1 × 12 months)

DAK-Gesundheit, HamburgTED 411186-2026

€11 lot, 2 years

Tue 5 Jun12:00 in Berlin

950days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Hydroxycarbamid (excluding Dafo. FTA), ATC L01XX05 for the period from 01.08.2026 to 31.07.2028 (including V.-Option 1x12 Mon)

DAK-Gesundheit, HamburgTED 411302-2026

€11 lot, 2 years

Tue 5 Jun12:00 in Berlin

950days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Colistin, ATC J01XB01 for the period 01.08.2026 - 31.07.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 406977-2026

€11 lot, 2 years

Tue 5 Jun12:00 in Berlin

950days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Nifedipine, ATC C08CA05, for the period 01.08.2026 – 31.07.2028 (plus extension option 1 × 12 months)

DAK-Gesundheit, HamburgTED 410682-2026

€11 lot, 2 years

Tue 5 Jun12:00 in Berlin

950days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Palonosetron (excl. Dafo. WKA), ATC A04AA05, for the period 01.08.2026 – 31.07.2028 (plus extension option 1 × 12 months)

DAK-Gesundheit, HamburgTED 411224-2026

€11 lot, 2 years

Tue 5 Jun12:00 in Berlin

950days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Granisetron (excluding Dafo. ILO), ATC A04AA02 for the period 01.08.2026 - 31.07.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 410427-2026

€11 lot, 2 years

Tue 5 Jun12:00 in Berlin

950days

Conclusion of a Non-Exclusive Discount Agreement under § 130a Abs. 8 SGB V for the Active Ingredient Fesoterodin, ATC Code G04BD11, for the Period from 01.08.2026 to 31.07.2028 (including Extension Option for 1x12 Months)

DAK-Gesundheit, HamburgTED 406821-2026

€11 lot, 2 years

Tue 5 Jun12:00 in Berlin

950days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Calcipotriol (excluding Dafo. CRE), ATC D05AX02 for the period from 01.08.2026 to 31.07.2028 (including V.-Option 1x12 Mon)

DAK-Gesundheit, HamburgTED 412848-2026

€11 lot, 2 years

Tue 5 Jun12:00 in Berlin

950days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Granisetron (excluding Dafo. PFT), ATC A04AA02 for the period 01.08.2026 - 31.07.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 410634-2026

€11 lot, 2 years

Tue 5 Jun12:00 in Berlin

950days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Varenicline, ATC N07BA03, for the period 01.08.2026 – 31.07.2028 (plus extension option 1 × 12 months)

DAK-Gesundheit, HamburgTED 410962-2026

€11 lot, 2 years

Tue 5 Jun12:00 in Berlin

950days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Clonazepam, ATC N03AE01 for the period 01.08.2026 - 31.07.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 409047-2026

€11 lot, 2 years

Tue 5 Jun12:00 in Berlin

950days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Brivaracetam, ATC N03AX23 for the period 01.09.2026 - 31.08.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 496840-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.